[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Biotech Hangout posts on X about $xbi, $azn, $akro, $novo the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks XXXX% currencies XXXX% finance XXXX% exchanges XXXX% social networks XXXX% technology brands XXXX%
Social topic influence $xbi 2.04%, $azn 2.04%, $akro 1.02%, $novo 1.02%, $bmyorbital 1.02%, $mplt 1.02%, ipo 1.02%, $aznalgen 1.02%, $snybenchsci 1.02%, $101m XXXX%
Top accounts mentioned or mentioned by @samfazeli8 @bradloncar @ericschmidt151 @matteispaul @tlorriman @timopler @biotech1 @daphnezohar @cngarabedian @yaronwerber @yaireinhorn @mbrushstocks @nkjellson @adamfeuerstein @bioinvestor24 @jmaraganore @artsstocks @thenorthstar5 @gline @brianskorney
Top assets mentioned Bitcoin Incognito (XBI) AstraZeneca PLC (AZN) Akropolis (AKRO) Dyne Therapeutics, Inc. Common Stock (DYN) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Arrowhead Research Corporation (ARWR) Merus N.V. Common Shares (MRUS) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)
Top posts by engagements in the last XX hours
"On todays #BiotechHangout @t_lorriman @BrianSkorney @SamFazeli8 @YaronWerber & @luba_greenwood will cover deals & financings: $AKRO/$NOVO #MASH deal $BMY/Orbital deal MapLight ($MPLT) IPO AI Pharma deals: $AZN/Algen $SNY/BenchSci Nilo Therapeutics $101M Series A Ascentas $325M first biotech fund company news: $RCUS #ccRCC data $SKYE CBeyond Phase 2a data $DYN DM1 data & #WMS2025 DMD presentations $IONS Innovation Day regulatory: $LXEO FDA update Peter Marks joins $LLY plus board evolution & effective vs. ineffective boards much more:"
X Link @BiotechCH 2025-10-10T13:35Z 15.1K followers, 5850 engagements
"On todays #BiotechHangout @MatteisPaul @SamFazeli8 @JMaraganore @soowannaway (Graig Suvannaveijh) discuss the $XBI & sector performance drivers $SNYs X% stock dip despite Ph3 eczema success $INSMs incredible year & readthrough from $UTHRs Ph3 IPF data Corsera Health $50M launch #ESC2025: $IONS & $ARWR ApoC3 data ASO vs RNAi discussion tracking upcoming data: big year for AD readouts plus QUREs AMT-130 $HRMYs ZYN00 #WCLC25: $SMMTs ivonescimab & $AZNs FLAURA2 $AXSM AXS-05/Auvelity expected sNDA submission plus discussion themes: obesity readouts - is obesity a zero sum game biomarkers - do"
X Link @BiotechCH 2025-09-05T12:59Z 15.1K followers, 5278 engagements
"Why did $AZN choose Algen @luba_greenwood explains: Algens technology provides AI and also combines functional genomics CRISPR screening and CRISPR modulation. It maps out a causal link between gene regulation and disease progression in human cell types They're using high throughput screening AI models all to figure out which genes are therapeutically actionable and which ones are not. So it will help a company like $AZN with translation from human biology and our understanding into immunology and finding novel targets around which they'll have exclusive rights I think it's a great deal and"
X Link @BiotechCH 2025-10-10T16:51Z 15.1K followers, XXX engagements
"On todays #BiotechHangout @EricSchmidt151 @SamFazeli8 @BrianSkorney & @YaronWerber cover the latest macro news: TrumpRx MFN pricing/tariffs $PFE/White House deal $AZN moving to NYSE $XBI broke XXX are we in a biotech bull market George Tidmarshs LinkedIn posts FDA derails $IOBTs cancer vaccine plan $APLTs stock volatility company news: $GMAB/$MRUS deal & impact for $BCAX $MLTX #HidradenitisSuppurativa data $LRMR #FriedreichsAtaxia data & stock fall $ENTA RSV data & big stock reversal Q4 conferences: #ESMO2025 preview Q4 earnings season plus $GSK CEO change & more:"
X Link @BiotechCH 2025-10-03T13:01Z 15.1K followers, 7915 engagements